Publication | Closed Access

Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma

Hematological MalignancyTherapy-induced Clonal SelectionMedicineMixed-phenotype Acute LeukemiaHematologyMultiple MyelomaCell TransplantationCytogenetic ArchitectureRadiation OncologyImmunotherapyCell BiologyTumor MicroenvironmentCancer ResearchHealth Sciences